Chirag Vasavda, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prurigo | 2 | 2023 | 21 | 1.100 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2022 | 86 | 0.840 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2022 | 167 | 0.800 |
Why?
|
| Dermatitis | 1 | 2023 | 199 | 0.780 |
Why?
|
| Biological Science Disciplines | 1 | 2021 | 52 | 0.750 |
Why?
|
| Bilirubin | 2 | 2019 | 425 | 0.750 |
Why?
|
| Superoxides | 1 | 2019 | 387 | 0.630 |
Why?
|
| Heme | 2 | 2019 | 306 | 0.630 |
Why?
|
| Blood Donors | 1 | 2020 | 355 | 0.620 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2017 | 87 | 0.610 |
Why?
|
| Scintillation Counting | 1 | 2017 | 38 | 0.590 |
Why?
|
| Plasma | 1 | 2020 | 575 | 0.570 |
Why?
|
| Carotid Body | 5 | 2017 | 26 | 0.560 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 2077 | 0.530 |
Why?
|
| Hydrogen Sulfide | 4 | 2017 | 137 | 0.490 |
Why?
|
| GTP-Binding Proteins | 2 | 2017 | 969 | 0.460 |
Why?
|
| Astrocytes | 1 | 2021 | 1273 | 0.450 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2022 | 1222 | 0.420 |
Why?
|
| Cholestasis | 3 | 2019 | 378 | 0.400 |
Why?
|
| Pruritus | 3 | 2019 | 361 | 0.400 |
Why?
|
| Phosphoproteins | 1 | 2020 | 2440 | 0.390 |
Why?
|
| Antioxidants | 1 | 2019 | 1658 | 0.390 |
Why?
|
| Education, Medical | 1 | 2021 | 1722 | 0.330 |
Why?
|
| Receptors, Opioid, mu | 2 | 2017 | 182 | 0.280 |
Why?
|
| Neurons | 2 | 2021 | 9336 | 0.250 |
Why?
|
| Telemedicine | 1 | 2021 | 2874 | 0.240 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5532 | 0.240 |
Why?
|
| Neural Stem Cells | 2 | 2021 | 851 | 0.230 |
Why?
|
| Heme Oxygenase (Decyclizing) | 4 | 2017 | 171 | 0.220 |
Why?
|
| Physicians | 1 | 2021 | 4569 | 0.210 |
Why?
|
| Carbon Monoxide | 2 | 2017 | 531 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3134 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.210 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 182 | 0.200 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2022 | 261 | 0.190 |
Why?
|
| Racemases and Epimerases | 1 | 2021 | 113 | 0.190 |
Why?
|
| Signal Transduction | 3 | 2021 | 23398 | 0.190 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2022 | 896 | 0.180 |
Why?
|
| Tissue Culture Techniques | 1 | 2021 | 291 | 0.180 |
Why?
|
| Clinical Medicine | 1 | 2021 | 147 | 0.170 |
Why?
|
| src-Family Kinases | 1 | 2022 | 551 | 0.170 |
Why?
|
| Receptors, Neuropeptide | 1 | 2019 | 111 | 0.160 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2017 | 944 | 0.160 |
Why?
|
| Peer Review, Research | 1 | 2021 | 329 | 0.150 |
Why?
|
| Immunization, Passive | 1 | 2020 | 623 | 0.150 |
Why?
|
| Sulfur Radioisotopes | 1 | 2017 | 116 | 0.150 |
Why?
|
| Serine | 1 | 2021 | 825 | 0.150 |
Why?
|
| Mice, Knockout | 8 | 2021 | 14563 | 0.150 |
Why?
|
| Brain | 2 | 2021 | 26345 | 0.150 |
Why?
|
| Connective Tissue | 1 | 2019 | 415 | 0.150 |
Why?
|
| Bile Acids and Salts | 1 | 2019 | 368 | 0.150 |
Why?
|
| Mice | 12 | 2022 | 81154 | 0.140 |
Why?
|
| Health Facilities | 1 | 2021 | 572 | 0.140 |
Why?
|
| Interleukins | 1 | 2021 | 791 | 0.140 |
Why?
|
| TRPV Cation Channels | 1 | 2017 | 237 | 0.140 |
Why?
|
| Editorial Policies | 1 | 2021 | 451 | 0.140 |
Why?
|
| Cystathionine gamma-Lyase | 4 | 2017 | 36 | 0.130 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3082 | 0.130 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2015 | 30 | 0.130 |
Why?
|
| HEK293 Cells | 4 | 2017 | 4204 | 0.130 |
Why?
|
| Patients | 1 | 2021 | 899 | 0.130 |
Why?
|
| Phosphorylation | 3 | 2022 | 8436 | 0.130 |
Why?
|
| Hepatitis B | 1 | 2020 | 693 | 0.120 |
Why?
|
| Sensory Receptor Cells | 1 | 2019 | 493 | 0.120 |
Why?
|
| Streptococcus pneumoniae | 1 | 2019 | 714 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2022 | 1400 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 2183 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2020 | 1301 | 0.110 |
Why?
|
| Transcytosis | 1 | 2013 | 44 | 0.110 |
Why?
|
| Animals | 15 | 2022 | 168660 | 0.110 |
Why?
|
| Ankyrins | 1 | 2013 | 128 | 0.110 |
Why?
|
| Oxygen | 2 | 2015 | 4189 | 0.110 |
Why?
|
| Pandemics | 3 | 2021 | 8385 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1582 | 0.100 |
Why?
|
| Mast Cells | 1 | 2019 | 1544 | 0.100 |
Why?
|
| Clathrin | 1 | 2013 | 267 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2020 | 2232 | 0.100 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 414 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 627 | 0.090 |
Why?
|
| Hepatitis C | 1 | 2020 | 1591 | 0.090 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 1429 | 0.090 |
Why?
|
| Neutrophils | 1 | 2022 | 3718 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2021 | 3740 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 21824 | 0.080 |
Why?
|
| Students, Medical | 1 | 2021 | 1862 | 0.080 |
Why?
|
| Cadherins | 1 | 2013 | 907 | 0.080 |
Why?
|
| Skin | 1 | 2021 | 4372 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2019 | 2961 | 0.070 |
Why?
|
| Humans | 17 | 2023 | 743811 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2021 | 19232 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 4463 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 3850 | 0.070 |
Why?
|
| Hypertension | 2 | 2016 | 8480 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 17439 | 0.060 |
Why?
|
| Respiration | 3 | 2017 | 1653 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5319 | 0.060 |
Why?
|
| Defensins | 1 | 2022 | 35 | 0.050 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2022 | 79 | 0.050 |
Why?
|
| United States | 2 | 2021 | 69859 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 12066 | 0.050 |
Why?
|
| Amino Acid Motifs | 2 | 2015 | 936 | 0.050 |
Why?
|
| Epirizole | 1 | 2020 | 3 | 0.050 |
Why?
|
| Trimipramine | 1 | 2020 | 3 | 0.050 |
Why?
|
| Perphenazine | 1 | 2020 | 34 | 0.050 |
Why?
|
| Trazodone | 1 | 2020 | 66 | 0.050 |
Why?
|
| Carbamazepine | 1 | 2020 | 229 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 2021 | 245 | 0.040 |
Why?
|
| Protein Isoforms | 2 | 2015 | 1729 | 0.040 |
Why?
|
| Bacteriocins | 1 | 2019 | 87 | 0.040 |
Why?
|
| Hyperbilirubinemia | 1 | 2019 | 77 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 11729 | 0.040 |
Why?
|
| Enterococcus faecium | 1 | 2019 | 99 | 0.040 |
Why?
|
| G-Protein-Coupled Receptor Kinase 5 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Risperidone | 1 | 2020 | 383 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2022 | 796 | 0.040 |
Why?
|
| Naloxone | 1 | 2020 | 365 | 0.040 |
Why?
|
| Rats, Inbred WKY | 1 | 2017 | 158 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 2019 | 289 | 0.040 |
Why?
|
| Rats, Inbred SHR | 1 | 2017 | 195 | 0.040 |
Why?
|
| Risk Factors | 1 | 2023 | 72252 | 0.030 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 562 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2021 | 2725 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2017 | 3749 | 0.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2021 | 985 | 0.030 |
Why?
|
| Career Choice | 1 | 2021 | 743 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 1608 | 0.030 |
Why?
|
| Adrenal Medulla | 1 | 2014 | 58 | 0.030 |
Why?
|
| Gases | 1 | 2015 | 197 | 0.030 |
Why?
|
| Splanchnic Nerves | 1 | 2014 | 9 | 0.030 |
Why?
|
| Solitary Nucleus | 1 | 2014 | 63 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2022 | 1453 | 0.030 |
Why?
|
| Calpain | 1 | 2014 | 150 | 0.030 |
Why?
|
| Male | 7 | 2021 | 349776 | 0.030 |
Why?
|
| Protein Binding | 2 | 2017 | 9377 | 0.030 |
Why?
|
| Catecholamines | 1 | 2014 | 387 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2009 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2014 | 8300 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2020 | 1058 | 0.030 |
Why?
|
| Reflex | 1 | 2014 | 365 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 1988 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2021 | 4221 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 595 | 0.020 |
Why?
|
| Leucine | 1 | 2013 | 559 | 0.020 |
Why?
|
| Calcium | 2 | 2015 | 5755 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2020 | 1910 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2281 | 0.020 |
Why?
|
| Cysteine | 1 | 2015 | 871 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2177 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 5524 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1986 | 0.020 |
Why?
|
| Species Specificity | 1 | 2014 | 2480 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 1733 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2022 | 5021 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 2837 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 2839 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1114 | 0.020 |
Why?
|
| Dogs | 1 | 2013 | 3911 | 0.020 |
Why?
|
| Rats | 2 | 2014 | 24250 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 1869 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2020 | 3057 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2020 | 6188 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2110 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9440 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7172 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2021 | 11478 | 0.010 |
Why?
|
| Body Weight | 1 | 2014 | 4670 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13809 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25032 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12744 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 11360 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 18107 | 0.010 |
Why?
|
| Cell Line | 1 | 2013 | 15993 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 53250 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18027 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19894 | 0.010 |
Why?
|
| Female | 3 | 2021 | 380020 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 163178 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 29777 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 213241 | 0.000 |
Why?
|
| Adult | 1 | 2021 | 213889 | 0.000 |
Why?
|